Cyclerion Therapeutics, Inc. (CYCN) — 10-Q Filings
All 10-Q filings from Cyclerion Therapeutics, Inc.. Browse 5 Quarterly Report reports with AI-powered summaries and risk analysis.
10-Q Filings (5)
-
Cyclerion Narrows Losses, Eyes Strategic Alternatives Amid Cash Burn
— Aug 5, 2025 Risk: high
Cyclerion Therapeutics, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year periods. The company's net los -
Cyclerion Therapeutics Files Q1 2025 10-Q, Details Equity Transactions
— May 6, 2025 Risk: medium
Cyclerion Therapeutics, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial activities and equity transactions, including pre -
Cyclerion Therapeutics Files Q3 2024 10-Q
— Nov 14, 2024 Risk: medium
Cyclerion Therapeutics, Inc. filed its Q3 10-Q report for the period ending September 30, 2024. The filing details financial performance and operational updates -
Cyclerion Therapeutics Files Q2 2024 10-Q
— Aug 7, 2024 Risk: medium
Cyclerion Therapeutics, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details financial performance and operational updates for the second -
Cyclerion Therapeutics Files 10-Q for Period Ending March 31, 2024
— May 7, 2024 Risk:
Cyclerion Therapeutics, Inc. (CYCN) filed a Quarterly Report (10-Q) with the SEC on May 7, 2024. Cyclerion Therapeutics, Inc. filed a 10-Q report for the period
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX